These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 7218164)

  • 1. Symposium on myocardial ischemia and reperfusion. Grenoble, September 17th, 1979.
    J Physiol (Paris); 1980; 76(7):749-829. PubMed ID: 7218164
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prehospital and emergency treatment: coronary flow recovery and myocardial reperfusion].
    Zhang W; Shen H;
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Jun; 15(6):376-7. PubMed ID: 12837179
    [No Abstract]   [Full Text] [Related]  

  • 3. No reflow phenomenon in coronary heart disease.
    Ito H
    J Cardiol; 2001; 37 Suppl 1():39-42. PubMed ID: 11433826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signalling pathways in ischaemic postconditioning.
    Hausenloy DJ
    Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A symposium: Detection, quantification and clinical significance of silent myocardial ischemia in coronary artery disease. November 10, 1984, Miami Beach, Florida.
    Am J Cardiol; 1986 Aug; 58(4):1B-60B. PubMed ID: 3751898
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathophysiology of myocardial ischemia].
    Baumgart D; Heusch G
    Klin Anasthesiol Intensivther; 1995; 47():3-45. PubMed ID: 7715178
    [No Abstract]   [Full Text] [Related]  

  • 7. Association between thrombolysis in myocardial infarction myocardial perfusion grade, biomarkers, and clinical outcomes among patients with moderate- to high-risk acute coronary syndromes: observations from the randomized trial to evaluate the relative PROTECTion against post-PCI microvascular dysfunction and post-PCI ischemia among antiplatelet and antithrombotic agents-Thrombolysis In Myocardial Infarction 30 (PROTECT-TIMI 30).
    Gibson CM; Kirtane AJ; Morrow DA; Palabrica TM; Murphy SA; Stone PH; Scirica BM; Jennings LK; Herrmann HC; Cohen DJ; McCabe CH; Braunwald E;
    Am Heart J; 2006 Oct; 152(4):756-61. PubMed ID: 16996854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial ischemia in coronary disease.
    Selwyn AP; Ganz P
    N Engl J Med; 1988 Apr; 318(16):1058-60. PubMed ID: 3352700
    [No Abstract]   [Full Text] [Related]  

  • 9. Myocardium salvaged by coronary artery reperfusion responds appropriately to cardiovascular stress.
    Cox DA; Patrick TA; Vatner SF
    Trans Assoc Am Physicians; 1981; 94():333-40. PubMed ID: 7344227
    [No Abstract]   [Full Text] [Related]  

  • 10. Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
    Chen H; Zhang YC; Li D; Phillips MI; Mehta P; Shi M; Mehta JL
    J Pharmacol Exp Ther; 2000 Aug; 294(2):722-7. PubMed ID: 10900253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
    Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of basic fibroblast growth factor on left ventricular geometry in rats subjected to coronary occlusion and reperfusion.
    Scheinowitz M; Kotlyar AA; Zimand S; Leibovitz I; Varda-Bloom N; Ohad D; Goldberg I; Engelberg S; Savion N; Eldar M
    Isr Med Assoc J; 2002 Feb; 4(2):109-13. PubMed ID: 11875982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion.
    Reffelmann T; Kloner RA
    Basic Res Cardiol; 2006 Sep; 101(5):359-72. PubMed ID: 16915531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic myocardial ischemia--hibernating myocardium: characteristics and limits].
    Heusch G; Schulz R
    Z Kardiol; 1993; 82 Suppl 5():133-41. PubMed ID: 8154154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].
    Strauer BE; Heidland UE; Heintzen MP; Schwartzkopff B
    Z Kardiol; 1995 Nov; 84(11):898-910. PubMed ID: 8571641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symposium on the physiology and pathology of the coronary circulation and coronary heart disease. Proceedings of the 6th Triennial Conference of the National Heart Foundation of Australia.
    Am J Cardiol; 1983 Jul; 52(2):1A-118A. PubMed ID: 6869254
    [No Abstract]   [Full Text] [Related]  

  • 17. A symposium: The concept of the total ischemic burden. September 14, 1986, Washington, DC.
    Am J Cardiol; 1987 Mar; 59(7):1C-38C. PubMed ID: 3825925
    [No Abstract]   [Full Text] [Related]  

  • 18. A symposium: Myocardial ischemia--current status and future directions. June 12-14, 1987, Kyoto, Japan. Proceedings.
    Am J Cardiol; 1989 Mar; 63(10):1E-120E. PubMed ID: 2923046
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular Biology Working Group: The Canadian Initiative--Risk Intervention. August 1997. Proceedings of a symposium.
    Can J Cardiol; 1998 Jul; 14 Suppl D():1D-34D. PubMed ID: 9722335
    [No Abstract]   [Full Text] [Related]  

  • 20. A Symposium: Coronary Artery Disease: Mechanisms for Myocardial Protection. Aventura, Florida, December 6-7, 1991.
    Am J Cardiol; 1992 Nov; 70(16):1F-48F. PubMed ID: 1359780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.